Anti-co Spofa suppositories
Macela, A.
Casopis Lekaru Ceskych 110(36): 853-854
1971
ISSN/ISBN: 0008-7335 PMID: 5093698 Document Number: 41456
Document emailed within 1 workday
Related Documents
Rizzi, B.; Lodigiani, F.; Terni, E.; Chiavenna, F. 1979: A double-blind, proctoscopic and clinical comparison of flurbiprofen suppositories and ibuprofen suppositories in osteoarthrosis Panminerva Medica 21(4): 173-180Tantó, M.; Ecsy, Z.; Selmeczi, B.; Regdon, G. 1990: Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories Acta Pharmaceutica Hungarica 60(4): 143-148
Doury, P. 1984: Comparative study of flurbiprofen 150 mg suppositories and diclofenac 100 mg suppositories in arthrosis Panminerva Medica 26(1): 55-56
Masiakowski, J.; Cieszyński, T.; Dyderski, S.; Perz, A. 1984: Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation Acta Poloniae Pharmaceutica 41(1): 99-104
Loendersloot, E.W. 1985: Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis Gynakologische Rundschau 25(Suppl): 99-104
Macela, A. 1970: Clofibrate Spofa Casopis Lekaru Ceskych 109(30): 700-701
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Semonský, M.; Zikán, V.; Veselá, H. 1973: Cytembena Spofa--a new antineoplastic agent Ceskoslovenska Farmacie 22(7): 313-321
Oláh, Z. 1971: Use of Clofibrate SPOFA in the treatment of diabetic retinopathy Ceskoslovenska Oftalmologie 27(5): 315-318
Novotný, P. 1972: Pyrvinium Spofa. new drug for the treatment of enterobiasis Casopis Lekaru Ceskych 111(36): 841-842
Drobný, M.; Wolfová, E.; Adamkov, J.; Bevilaqua, L.; Fundárek, J.; Pithová, B.; Knéslová, L. 1979: Effectiveness of fenalgin SPOFA in lumboischiadic syndrome Bratislavske Lekarske Listy 71(4): 421-428
Masáreová, E.; Inczinger, F.; Bózner, A. 1971: Influencing of the isoprenaline necrosis of the myocardium by ATP-Spofa administration Ceskoslovenska Patologie 7(2): 109-112
Klener, P.; Donner, L. 1975: Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas Neoplasma 22(1): 55-62
Grafnetterová, J.; König, J.; Krepelka, J.; Cerný, A.; Klíma, J.; Krebs, V.; Charvát, J. 1985: Problems with the Czechoslovak cytostatic agent Benin Spofa Casopis Lekaru Ceskych 124(26): 820-823
Cernohorský, D.; Král, B.; Hamet, A.; Eliás, J.; Tilser, P.; Rozánek, P.; Sramar, V.; Koudelka, V. 1986: Effect of dihydralazine Spofa on precapillary pulmonary hypertension Vnitrni Lekarstvi 32(9): 855-861
Navrátil, J.; Hrbek, J.; Dvorák, M. 1972: The therapeutic effect of Stenolon Spofa on female neurotic patients Activitas Nervosa Superior 14(2): 102-103
Havlik, J.; Holý, M. 1976: Erythromycin stearate Spofa--coated tablets for pediatric practice Ceskoslovenska Pediatrie 31(7): 402-404
Janda, J.; Marek, V.; Reitspiesová, K.; Sikut, M.; Korous, J. 1982: Standardized concentration test in school children using Adiuretin Spofa Ceskoslovenska Pediatrie 37(5): 285-288
Petrásek, J.; Cakrtová, M.; Dejmal, V. 1973: Rheologic situation in the vascular bed after infusion of a macromolecular solution (Rheodextran Spofa) Casopis Lekaru Ceskych 112(1): 23-25
Dvorák, K.; Presl, J. 1986: Biological testing of methenmadinone acetate (Superlutin Spofa) in clinical trials Ceskoslovenska Gynekologie 51(9): 714-719